SCHEMBL120224

SCHEMBL120224

CC(N)COC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17678837 0.77 GABRP (0.31)
SCHEMBL21518266 0.77 CA1 (0.36)
SCHEMBL20485768 0.77 ALDH1A1 (0.39)
SCHEMBL25812 0.77
SCHEMBL28213189 0.74
SCHEMBL27257823 0.74
Ammonia Solution, Strong SCHEMBL28283558 0.74
Hydrochloric Acid SCHEMBL5363750 0.74
SCHEMBL6201194 0.74
SCHEMBL12913667 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0725783-B1 2-(PYRAZOL-3-YL)CARBAPENEM DERIVATIVES SMITHKLINE BEECHAM PLC (GB) 2002-12-18 EP claimed
CN-116327950-A Use of a composition for the treatment of neuropsychiatric symptoms of neurodegenerative diseases 阿泽范药品公司 2023-06-27 CN disclosed
CN-116139282-A Compositions and methods for treating neurodegenerative diseases 阿泽范药品公司 2023-05-23 CN disclosed
CN-106459021-B Compositions and methods for treating neurodegenerative diseases 阿泽范药品公司 2023-04-07 CN disclosed
CN-111295373-A Compositions and methods for treating brain injury 阿泽凡药物公司 2020-06-16 CN disclosed
US-20130131032-A1 NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION REVAAX PHARMACEUTICALS, LLC (US) 2013-05-23 US disclosed
EP-2424498-A1 CLAVULANATE FORMULATION FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS Rexahn Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
US-20110257147-A1 NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION REVAAX PHARMACEUTICALS, LLC (US) 2011-10-20 US disclosed
EP-1212055-B1 Neurotherapeutic composition comprising a beta-lactam compound REVAAX PHARMACEUTICALS LLC (US) 2011-08-03 EP disclosed
EP-2305251-A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of sexual disorder Revaax Pharmaceuticals LLC (US) 2011-04-06 EP disclosed
EP-0548186-A1 CEPHALOSPORIN DERIVATIVES AND THEIR HOMOLOGUES. BEECHAM GROUP PLC (GB) 1993-06-30 EP disclosed
EP-0540606-A1 CEPHALOSPORINS AND HOMOLOGUES, PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP plc (GB) 1993-05-12 EP disclosed
EP-0521887-A1 CEPHALOSPORINS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Beecham Group p.l.c. (GB) 1993-01-13 EP disclosed
EP-0504216-A1 CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Beecham Group p.l.c. (GB) 1992-09-23 EP disclosed
WO-1992004353-A1 CEPHALOSPORIN DERIVATIVES AND THEIR HOMOLOGUES BEECHAM GROUP PLC (GB) 1992-03-19 WO disclosed
WO-1991014692-A1 CEPHALOSPORINS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1991-10-03 WO disclosed
EP-0416814-A2 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates BEECHAM GROUP PLC (GB) 1991-03-13 EP disclosed
EP-0416810-A2 Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates Beecham Group p.l.c. (GB) 1991-03-13 EP disclosed
EP-0308559-A2 Cephalosporins, process for their preparation, pharmaceutical compositions containing them and intermediates BEECHAM GROUP PLC (GB) 1989-03-29 EP disclosed
EP-0219926-A2 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1987-04-29 EP disclosed